NxStage Kidney Care Opens Dialysis Center in Memphis, Tennessee

Company offers comfortable environment focused on home training for dialysis patients in Memphis area

LAWRENCE, Mass. – (Jan 7, 2016) NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of its dialysis center in Germantown, a suburb of Memphis, Tennessee. NxStage Kidney Care Memphis is focused on providing home dialysis training and education in an intimate setting for people with kidney failure and their families. The facility also welcomes home dialysis patients seeking short-term respite care, as well as patients who are traveling.

"We are proud to bring NxStage Kidney Care to the Memphis area and provide patients with flexible therapy options including home hemodialysis (HHD) with the NxStage® System One™ and peritoneal dialysis (PD),” said Dr. Jo Pinnaka, Medical Director at NxStage Kidney Care Memphis. “As a team, we work to design a personalized therapy plan that best fits our patients’ health needs and lifestyle goals.”

“As we continue to expand, we remain focused on the importance of educating patients on home therapy options,” said Robert Brown, President of NxStage Kidney Care. “Our approach to dialysis is to offer patients the opportunity to regain control of their lives.”

NxStage Kidney Care Memphis is located at 8040 Wolf River Boulevard, Suite 101, Germantown, TN 38138. For more information about NxStage Kidney Care and the therapy options offered please visit www.nxstagekidneycare.com or call (901) 290-9075.

About NxStage Kidney Care

NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient-centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit www.nxstagekidneycare.com or call (866) 694-2707.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Kristen K. Sheppard, Esq.
ksheppard@nxstage.com
Tel: (978) 332-5923